KOSDAQ - Delayed Quote KRW
HYUNDAI BIOLAND Co.,Ltd. (052260.KQ)
4,595.00
-60.00
(-1.29%)
At close: 3:30:30 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
123,224,611.16
119,519,059.19
96,719,665.54
99,153,525.12
102,801,832.23
Cost of Revenue
68,458,214.73
66,672,855.55
56,924,837.06
63,503,600.42
65,510,861.36
Gross Profit
54,766,396.43
52,846,203.64
39,794,828.48
35,649,924.70
37,290,970.87
Operating Expense
26,375,325
36,481,660
26,330,498
26,595,216
26,633,053
Operating Income
26,612,349.43
16,364,543.64
13,464,330.48
9,054,708.70
10,657,917.87
Net Non Operating Interest Income Expense
804,952.14
361,657.09
419,505.66
-810,553.92
-1,148,489.18
Pretax Income
17,184,931.20
15,883,618.79
17,445,663.15
6,844,226.32
-15,164,998.49
Tax Provision
3,810,580.98
3,573,022.16
3,601,131.27
2,079,899.81
-3,478,838.08
Net Income Common Stockholders
-4,511,575.44
5,703,130.97
8,056,171.30
4,764,327
-11,686,160.41
Basic EPS
-150.39
--
134.00
159.00
-389.50
Diluted EPS
-150.39
--
134.00
159.00
-389.50
Basic Average Shares
30,016.48
--
30,004.36
29,964.32
30,002.98
Diluted Average Shares
30,016.48
--
30,004.36
29,964.32
30,002.98
Total Operating Income as Reported
17,324,360.90
16,364,543.18
13,464,330.71
9,054,708.90
10,656,917.74
Rent Expense Supplemental
15,619
70,041
58,371
133,585
141,421
Total Expenses
96,612,261.73
103,154,515.55
83,255,335.06
90,098,816.42
92,143,914.36
Net Income from Continuing & Discontinued Operation
-4,511,575.44
5,703,130.97
8,056,171.30
4,764,327
-11,686,160.41
Normalized Income
15,699,942.06
14,720,123.57
11,397,368.78
6,015,323.70
7,897,566.18
Interest Income
317,316
863,205
970,192
466,017
185,782
Interest Expense
1,249,985
501,548
550,688
1,276,571
1,334,272
Net Interest Income
804,952.14
361,657.09
419,505.66
-810,553.92
-1,148,489.18
EBIT
26,195,494.20
16,385,166.79
17,996,351.15
8,120,797.32
-13,830,726.49
EBITDA
26,195,494.20
22,903,408.79
24,296,893.15
14,448,817.32
-5,269,292.49
Reconciled Cost of Revenue
68,458,214.73
66,672,855.55
56,924,837.06
63,503,600.42
65,510,861.36
Reconciled Depreciation
7,204,944
6,518,242
6,300,542
6,328,020
8,561,434
Net Income from Continuing Operation Net Minority Interest
13,374,349.21
12,310,596.62
13,844,531.87
4,764,327
-11,686,160.41
Total Unusual Items Excluding Goodwill
-2,988,194
-3,108,867
3,083,700
-1,797,128
-25,413,581
Total Unusual Items
-2,988,194
-3,108,867
3,083,700
-1,797,128
-25,413,581
Normalized EBITDA
29,183,688.20
26,012,275.79
21,213,193.15
16,245,945.32
20,144,288.51
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-662,601.15
-699,340.05
636,536.91
-546,131.30
-5,829,854.41
12/31/2021 - 5/17/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade